Prostacyclin (PGI2) and thromboxane A2 interaction in vivo. Regulation by aspirin and relationship with anti-thrombotic therapy
- 1 September 1978
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 13 (3), 489-500
- https://doi.org/10.1016/0049-3848(78)90134-2
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Prostacyclin is a circulating hormoneNature, 1978
- Generation of prostacyclin by lungs in vivo and its release into the arterial circulationNature, 1978
- DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLINThe Lancet, 1978
- Vascular actinos of arachidonic acid and its metabolites in perfused mesenteric and femoral beds of the dogEuropean Journal of Pharmacology, 1978
- An antiserum to 5,6-dihydro prostacyclin (PGI1) which also binds prostacyclinProstaglandins, 1978
- A synthesis of prostacyclin sodium saltTetrahedron Letters, 1977
- Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandinBiochemical and Biophysical Research Communications, 1977
- Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxidesProstaglandins, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Arachidonic Acid Causes Sudden Death in RabbitsScience, 1974